Lasa Supergenerics Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

54.86

62.54

66.95

70.18

109.29

Operating profit

5.09

-8.47

9.75

5.88

24.98

Interest

0.93

0.85

0.01

0.03

1.45

Gross profit

4.25

-9.30

9.76

5.89

23.57

EPS (Rs)

-0.99

-4.60

1.86

-3.18

3.05

Other income

0.09

0.01

0.02

0.04

0.04

Stock adjustment

-5.04

-1.92

7.00

-10.17

6.15

Raw material

41.86

57.14

32.94

55.27

57.23

Power and fuel

-

-

-

-

-

Employee expenses

3.28

6.25

2.29

7.64

6.31

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

9.67

9.54

14.96

11.56

14.62

Provisions made

-

-

-

-

-

Depreciation

5.33

6.16

7.07

6.92

7.79

Taxation

3.89

0.76

-0.84

-

3.35

Net profit / loss

-4.97

-18.69

7.57

-12.94

12.42

Extra ordinary item

-

-2.47

4.04

-11.90

-

Prior year adjustments

-

-

-

-

-

Equity capital

50.10

40.67

40.67

40.67

40.67

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

9.29

-13.54

14.56

8.38

22.85

GPM (%)

7.74

-14.87

14.57

8.39

21.55

NPM (%)

-9.05

-29.88

11.30

-18.43

11.36